Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bluebird Bio, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bluebird Bio, Inc. since year 2005.
(See page 1 of this report.) Table 2 shows the detailed insider transactions of Bluebird Bio, Inc. since 2005.
The reporting company's ticker symbol is BLUE. The reporting company's CIK number is 1293971.
The total value of stock buying since 2005 is $900,936.
The total value of stock sales since 2005 is $274,986,607.
The total value of stock option exercises since 2005 is $13,291,789.
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-06-06 | Gregory Philip D (Chief Scientific Officer) | Sale | 1,500 | 99.04 | 148,560 |
| 2017-06-06 | Gregory Philip D (Chief Scientific Officer) | Option Ex | 1,000 | 50.51 | 50,510 |
| 2017-06-06 | Lynch Daniel (Director) | Sale | 2,263 | 100.14 | 226,621 |
| 2017-06-06 | Lynch Daniel (Director) | Option Ex | 2,263 | 2.09 | 4,720 |
| 2017-06-05 | Davidson David (Chief Medical Officer) | Sale | 1,000 | 90.00 | 90,002 |
| 2017-06-05 | Davidson David (Chief Medical Officer) | Option Ex | 1,000 | 2.09 | 2,090 |
| 2017-06-05 | Lynch Daniel (Director) | Sale | 1,000 | 90.00 | 90,002 |
| 2017-06-05 | Lynch Daniel (Director) | Option Ex | 1,000 | 2.09 | 2,086 |
| 2017-06-01 | Davidson David (Chief Medical Officer) | Sale | 2,000 | 75.42 | 150,850 |
| 2017-06-01 | Davidson David (Chief Medical Officer) | Option Ex | 2,000 | 2.09 | 4,180 |
| 2017-06-01 | Gregory Philip D (Chief Scientific Officer) | Sale | 1,500 | 75.74 | 113,611 |
| 2017-06-01 | Gregory Philip D (Chief Scientific Officer) | Option Ex | 750 | 50.51 | 37,882 |
| 2017-05-25 | Lynch Daniel (Director) | Sale | 2,000 | 80.00 | 160,002 |
| 2017-05-25 | Lynch Daniel (Director) | Option Ex | 2,000 | 2.09 | 4,172 |
| 2017-05-10 | Walsh Jeffrey T. (Chief Financial) | Sale | 1,250 | 89.10 | 111,377 |
| 2017-05-10 | Walsh Jeffrey T. (Chief Financial) | Option Ex | 1,250 | 5.50 | 6,875 |
| 2017-05-01 | Davidson David (Chief Medical Officer) | Sale | 3,000 | 88.74 | 266,220 |
| 2017-05-01 | Davidson David (Chief Medical Officer) | Option Ex | 3,000 | 2.09 | 6,270 |
| 2017-05-01 | Gregory Philip D (Chief Scientific Officer) | Sale | 1,500 | 88.30 | 132,456 |
| 2017-05-01 | Gregory Philip D (Chief Scientific Officer) | Option Ex | 750 | 50.51 | 37,882 |
| 2017-04-27 | Lynch Daniel (Director) | Sale | 1,000 | 90.01 | 90,010 |
| 2017-04-27 | Lynch Daniel (Director) | Option Ex | 1,000 | 2.09 | 2,086 |
| 2017-04-26 | Cole Jason (Chief Legal Officer) | Option Ex | 3,750 | 22.53 | 84,487 |
| 2017-04-25 | Lynch Daniel (Director) | Sale | 2,000 | 86.75 | 173,500 |
| 2017-04-25 | Lynch Daniel (Director) | Option Ex | 2,000 | 2.09 | 4,172 |
| 2017-04-10 | Walsh Jeffrey T. (Chief Financial) | Sale | 1,250 | 87.38 | 109,225 |
| 2017-04-10 | Walsh Jeffrey T. (Chief Financial) | Option Ex | 1,250 | 5.50 | 6,875 |
| 2017-04-03 | Davidson David (Chief Medical Officer) | Sale | 3,000 | 91.21 | 273,633 |
| 2017-04-03 | Davidson David (Chief Medical Officer) | Option Ex | 3,000 | 2.09 | 6,270 |
| 2017-03-27 | Lynch Daniel (Director) | Sale | 1,000 | 90.00 | 90,000 |
| 2017-03-27 | Lynch Daniel (Director) | Option Ex | 1,000 | 2.09 | 2,086 |
| 2017-03-24 | Lynch Daniel (Director) | Sale | 2,000 | 87.37 | 174,732 |
| 2017-03-24 | Lynch Daniel (Director) | Option Ex | 2,000 | 2.09 | 4,172 |
| 2017-03-16 | Sullivan Eric (Principal Accounting Officer) | Sale | 411 | 99.00 | 40,689 |
| 2017-03-16 | Walsh Jeffrey T. (Chief Financial) | Sale | 3,543 | 100.07 | 354,562 |
| 2017-03-16 | Walsh Jeffrey T. (Chief Financial) | Option Ex | 3,543 | 3.79 | 13,445 |
| 2017-03-16 | Cole Jason (Chief Legal Officer) | Sale | 4,930 | 100.07 | 493,364 |
| 2017-03-16 | Cole Jason (Chief Legal Officer) | Option Ex | 4,930 | 22.53 | 111,072 |
| 2017-03-16 | Lynch Daniel (Director) | Sale | 237 | 100.07 | 23,717 |
| 2017-03-16 | Lynch Daniel (Director) | Option Ex | 237 | 2.09 | 494 |
| 2017-03-03 | Maraganore John (Director) | Sale | 13,839 | 85.02 | 1,176,647 |
| 2017-03-03 | Maraganore John (Director) | Option Ex | 13,839 | 3.22 | 44,616 |
| 2017-03-01 | Davidson David (Chief Medical Officer) | Sale | 5,000 | 89.83 | 449,155 |
| 2017-03-01 | Davidson David (Chief Medical Officer) | Option Ex | 5,000 | 2.09 | 10,450 |
| 2017-03-01 | Schenkein David P (Director) | Sale | 5,000 | 89.53 | 447,635 |
| 2017-03-01 | Schenkein David P (Director) | Option Ex | 5,000 | 8.16 | 40,780 |
| 2017-03-01 | Cole Jason (Chief Legal Officer) | Sale | 5,225 | 90.32 | 471,911 |
| 2017-03-01 | Cole Jason (Chief Legal Officer) | Option Ex | 5,225 | 50.51 | 263,914 |
| 2017-03-01 | Lynch Daniel (Director) | Sale | 2,000 | 90.32 | 180,636 |
| 2017-03-01 | Lynch Daniel (Director) | Option Ex | 2,000 | 2.09 | 4,172 |
| 2017-02-28 | Sullivan Eric (Principal Accounting Officer) | Sale | 285 | 89.00 | 25,365 |
| 2017-02-15 | Mandell James (Director) | Sale | 1,050 | 80.22 | 84,235 |
| 2017-02-15 | Mandell James (Director) | Option Ex | 1,050 | 25.16 | 26,418 |
| 2017-02-15 | Cole Jason (Chief Legal Officer) | Sale | 666 | 80.22 | 53,429 |
| 2017-02-15 | Lynch Daniel (Director) | Sale | 150 | 80.22 | 12,033 |
| 2017-02-15 | Lynch Daniel (Director) | Option Ex | 150 | 2.09 | 312 |
| 2017-02-14 | Mandell James (Director) | Sale | 5,950 | 80.01 | 476,077 |
| 2017-02-14 | Mandell James (Director) | Option Ex | 5,950 | 23.30 | 138,605 |
| 2017-02-14 | Cole Jason (Chief Legal Officer) | Sale | 3,772 | 80.01 | 301,809 |
| 2017-02-14 | Lynch Daniel (Director) | Sale | 850 | 80.01 | 68,011 |
| 2017-02-14 | Lynch Daniel (Director) | Option Ex | 850 | 2.09 | 1,773 |
| 2017-02-01 | Davidson David (Chief Medical Officer) | Sale | 2,000 | 74.03 | 148,062 |
| 2017-02-01 | Davidson David (Chief Medical Officer) | Option Ex | 2,000 | 2.09 | 4,180 |
| 2017-01-31 | Mandell James (Director) | Sale | 8,000 | 75.04 | 600,320 |
| 2017-01-31 | Mandell James (Director) | Option Ex | 8,000 | 21.43 | 171,440 |
| 2017-01-27 | Mandell James (Director) | Sale | 5,000 | 70.10 | 350,500 |
| 2017-01-27 | Mandell James (Director) | Option Ex | 5,000 | 21.43 | 107,150 |
| 2017-01-27 | Davidson David (Chief Medical Officer) | Sale | 6,000 | 68.85 | 413,117 |
| 2017-01-27 | Davidson David (Chief Medical Officer) | Option Ex | 6,000 | 2.09 | 12,540 |
| 2017-01-27 | Lynch Daniel (Director) | Sale | 1,000 | 70.09 | 70,092 |
| 2017-01-27 | Lynch Daniel (Director) | Option Ex | 1,000 | 2.09 | 2,086 |
| 2017-01-05 | Sullivan Eric (Principal Accounting Officer) | Sale | 229 | 67.10 | 15,365 |
| 2017-01-05 | Davidson David (Chief Medical Officer) | Sale | 923 | 67.10 | 61,933 |
| 2017-01-05 | Leschly Nick (President and CEO) | Sale | 2,024 | 67.10 | 135,810 |
| 2017-01-05 | Walsh Jeffrey T. (Chief Financial) | Sale | 1,295 | 67.10 | 86,894 |
| 2017-01-05 | Cole Jason (Chief Legal Officer) | Sale | 549 | 67.10 | 36,837 |
| 2017-01-05 | Gregory Philip D (Chief Scientific Officer) | Sale | 790 | 67.10 | 53,008 |
| 2016-10-03 | Sullivan Eric (Principal Accounting Officer) | Sale | 416 | 67.00 | 27,870 |
| 2016-10-03 | Sullivan Eric (Principal Accounting Officer) | Option Ex | 416 | 22.59 | 9,395 |
| 2016-09-13 | Sullivan Eric (Principal Accounting Officer) | Sale | 416 | 59.00 | 24,544 |
| 2016-09-13 | Sullivan Eric (Principal Accounting Officer) | Option Ex | 416 | 22.59 | 9,395 |
| 2016-08-03 | Sullivan Eric (Principal Accounting Officer) | Sale | 416 | 59.00 | 24,544 |
| 2016-08-03 | Sullivan Eric (Principal Accounting Officer) | Option Ex | 416 | 22.59 | 9,395 |
| 2016-07-27 | Sullivan Eric (Principal Accounting Officer) | Sale | 2,912 | 55.01 | 160,177 |
| 2016-07-27 | Sullivan Eric (Principal Accounting Officer) | Option Ex | 2,912 | 22.59 | 65,767 |
| 2016-07-20 | Sullivan Eric (Principal Accounting Officer) | Sale | 1,950 | 45.09 | 87,933 |
| 2016-07-19 | Sullivan Eric (Principal Accounting Officer) | Sale | 857 | 45.40 | 38,907 |
| 2016-07-15 | Davidson David (Chief Medical Officer) | Sale | 1,000 | 45.08 | 45,078 |
| 2016-07-15 | Davidson David (Chief Medical Officer) | Option Ex | 1,000 | 2.09 | 2,090 |
| 2016-06-24 | Leschly Nick (President and CEO) | Option Ex | 19,826 | 3.79 | 75,200 |
| 2016-06-16 | Gregory Philip D (Chief Scientific Officer) | Sale | 2,931 | 39.52 | 115,833 |
| 2016-06-15 | Davidson David (Chief Medical Officer) | Sale | 1,000 | 40.11 | 40,112 |
| 2016-06-15 | Davidson David (Chief Medical Officer) | Option Ex | 1,000 | 2.09 | 2,090 |
| 2016-05-16 | Davidson David (Chief Medical Officer) | Sale | 1,000 | 38.73 | 38,729 |
| 2016-05-16 | Davidson David (Chief Medical Officer) | Option Ex | 1,000 | 2.09 | 2,090 |
| 2016-04-15 | Davidson David (Chief Medical Officer) | Sale | 1,000 | 49.63 | 49,630 |
| 2016-04-15 | Davidson David (Chief Medical Officer) | Option Ex | 1,000 | 2.09 | 2,090 |
| 2016-03-15 | Davidson David (Chief Medical Officer) | Sale | 1,000 | 46.37 | 46,366 |
| 2016-03-15 | Davidson David (Chief Medical Officer) | Option Ex | 1,000 | 2.09 | 2,090 |
| 2016-02-16 | Davidson David (Chief Medical Officer) | Sale | 1,000 | 45.18 | 45,176 |
| 2016-02-16 | Davidson David (Chief Medical Officer) | Option Ex | 1,000 | 2.09 | 2,090 |
| 2016-01-15 | Davidson David (Chief Medical Officer) | Sale | 1,000 | 44.39 | 44,392 |
| 2016-01-15 | Davidson David (Chief Medical Officer) | Option Ex | 1,000 | 2.09 | 2,090 |
| 2015-12-21 | Cole Jason (SVP, Secy. & General Counsel) | Option Ex | 4,438 | 22.53 | 99,988 |
| 2015-12-15 | Davidson David (Chief Medical Officer) | Sale | 1,000 | 58.55 | 58,546 |
| 2015-12-15 | Davidson David (Chief Medical Officer) | Option Ex | 1,000 | 2.09 | 2,090 |
| 2015-12-08 | Leschly Nick (President and CEO) | Buy | 9,682 | 51.75 | 501,062 |
| 2015-12-07 | Leschly Nick (President and CEO) | Option Ex | 66,720 | 3.22 | 215,105 |
| 2015-12-02 | Sullivan Eric (Principal Accounting Officer) | Sale | 416 | 81.13 | 33,751 |
| 2015-12-02 | Sullivan Eric (Principal Accounting Officer) | Option Ex | 416 | 22.59 | 9,395 |
| 2015-11-16 | Davidson David (Chief Medical Officer) | Sale | 2,000 | 71.14 | 142,284 |
| 2015-11-16 | Davidson David (Chief Medical Officer) | Option Ex | 2,000 | 2.09 | 4,180 |
| 2015-11-02 | Sullivan Eric (Principal Accounting Officer) | Sale | 416 | 77.87 | 32,393 |
| 2015-11-02 | Sullivan Eric (Principal Accounting Officer) | Option Ex | 416 | 22.59 | 9,395 |
| 2015-10-15 | Davidson David (Chief Medical Officer) | Sale | 2,000 | 79.93 | 159,866 |
| 2015-10-15 | Davidson David (Chief Medical Officer) | Option Ex | 2,000 | 2.09 | 4,180 |
| 2015-10-12 | Walsh Jeffrey T. (Chief Operating Officer) | Sale | 11,000 | 88.34 | 971,696 |
| 2015-10-12 | Walsh Jeffrey T. (Chief Operating Officer) | Option Ex | 11,000 | 2.09 | 22,990 |
| 2015-10-09 | Cole Jason (SVP, Secy. & General Counsel) | Sale | 5,000 | 87.20 | 436,019 |
| 2015-10-09 | Cole Jason (SVP, Secy. & General Counsel) | Option Ex | 5,000 | 22.53 | 112,650 |
| 2015-10-05 | Lynch Daniel (Director) | Sale | 3,000 | 100.69 | 302,070 |
| 2015-10-05 | Lynch Daniel (Director) | Option Ex | 3,000 | 2.09 | 6,258 |
| 2015-10-02 | Sullivan Eric (Principal Accounting Officer) | Sale | 416 | 86.24 | 35,877 |
| 2015-10-02 | Sullivan Eric (Principal Accounting Officer) | Option Ex | 416 | 22.59 | 9,395 |
| 2015-09-17 | Lynch Daniel (Director) | Sale | 1,500 | 140.06 | 210,088 |
| 2015-09-17 | Lynch Daniel (Director) | Option Ex | 1,500 | 2.09 | 3,129 |
| 2015-09-15 | Davidson David (Chief Medical Officer) | Sale | 2,000 | 130.75 | 261,495 |
| 2015-09-15 | Davidson David (Chief Medical Officer) | Option Ex | 2,000 | 2.09 | 4,180 |
| 2015-09-10 | Walsh Jeffrey T. (Chief Operating Officer) | Sale | 11,000 | 129.62 | 1,425,875 |
| 2015-09-10 | Walsh Jeffrey T. (Chief Operating Officer) | Option Ex | 11,000 | 5.50 | 60,500 |
| 2015-09-09 | Cole Jason (SVP, Secy. & General Counsel) | Sale | 2,000 | 136.84 | 273,684 |
| 2015-09-09 | Cole Jason (SVP, Secy. & General Counsel) | Option Ex | 2,000 | 22.53 | 45,060 |
| 2015-09-08 | Leschly Nick (President and CEO) | Sale | 125,000 | 134.78 | 16,847,250 |
| 2015-09-08 | Leschly Nick (President and CEO) | Option Ex | 125,000 | 5.50 | 687,500 |
| 2015-09-08 | Lynch Daniel (Director) | Sale | 7,000 | 132.49 | 927,437 |
| 2015-09-08 | Lynch Daniel (Director) | Option Ex | 7,000 | 2.09 | 14,601 |
| 2015-09-02 | Sullivan Eric (Principal Accounting Officer) | Sale | 416 | 130.94 | 54,471 |
| 2015-09-02 | Sullivan Eric (Principal Accounting Officer) | Option Ex | 416 | 22.59 | 9,395 |
| 2015-09-01 | Mandell James (Director) | Sale | 1,500 | 126.24 | 189,363 |
| 2015-09-01 | Mandell James (Director) | Option Ex | 1,500 | 21.43 | 32,145 |
| 2015-08-17 | Davidson David (Chief Medical Officer) | Sale | 2,000 | 125.83 | 251,664 |
| 2015-08-17 | Davidson David (Chief Medical Officer) | Option Ex | 2,000 | 2.09 | 4,180 |
| 2015-08-10 | Mandell James (Director) | Sale | 1,500 | 149.72 | 224,580 |
| 2015-08-10 | Mandell James (Director) | Option Ex | 1,500 | 21.43 | 32,145 |
| 2015-08-10 | Walsh Jeffrey T. (Chief Operating Officer) | Sale | 11,000 | 149.72 | 1,646,942 |
| 2015-08-10 | Walsh Jeffrey T. (Chief Operating Officer) | Option Ex | 11,000 | 2.09 | 22,990 |
| 2015-08-10 | Cole Jason (SVP, Secy. & General Counsel) | Sale | 2,000 | 149.72 | 299,446 |
| 2015-08-10 | Cole Jason (SVP, Secy. & General Counsel) | Option Ex | 2,000 | 22.53 | 45,060 |
| 2015-08-07 | Leschly Nick (President and CEO) | Sale | 125,000 | 142.25 | 17,781,125 |
| 2015-08-07 | Leschly Nick (President and CEO) | Option Ex | 125,000 | 3.22 | 403,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of BLUE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bluebird Bio, Inc. (symbol BLUE, CIK number 1293971) see the Securities and Exchange Commission (SEC) website.